In this Section |
263848 Breast Cancer Mapping for Community Health Advocacy: Results from an Expert Panel StudyTuesday, October 30, 2012
Objectives: To evaluate the utility of sub-county breast cancer mapping and articulate guidelines for its implementation by public health agencies. Methods: We convened an Expert Advisory Group (EAG) of breast cancer stakeholders from around California to elicit values, priorities, and preferred characteristics of protocols for proactive sub-county breast cancer mapping. Upon formulating a protocol, we applied it to nine years of data (2000-2008) describing invasive breast cancer in California for evaluation by the EAG. Results: Maps with sub-county resolution were seen to provide important information with a wide range of applications. Priorities included the avoidance of false positive findings, scientific credibility, and the provision of information elucidating social and environmental characteristics. A protocol utilizing Kulldorff's Scan Statistic along with post-analytic steps for refining results was elaborated; when applied to the data, four discrete regions with elevated rates of invasive breast cancer were identified and described. Conclusions: EAG priorities were readily translatable into a scientifically rigorous protocol that protected confidentiality and avoided statistically unstable rate estimates. Findings enabled participants to visualize geographically defined populations falling within and crossing county boundaries.
Learning Areas:
Advocacy for health and health educationBiostatistics, economics Communication and informatics Public health or related public policy Learning Objectives: Keywords: Breast Cancer, Community Health
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I have been principal or co-principal on multiple grants related to epidemiology and biostatistics, health communication, and public health informatics. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 4178.0: Statistical Poster Session
|